BRIEF-Karo Pharma Q1 EBITDA rose to SEK 89 mln

April 26 (Reuters) - Karo Pharma AB:

* KARO PHARMA DOUBLES SALES AND EARNINGS IN THE FIRST QUARTER

* Q1 NET SALES AMOUNTED TO MSEK 267.1 (139.3), EQUIVALENT TO AN INCREASE OF 91.7%

* Q1 GROSS MARGIN WAS 56.8% (53.7%) FOR PERIOD

* Q1 EBITDA AMOUNTED TO MSEK 88.7 (43.7) Source text for Eikon: Further company coverage: (Reporting By Stockholm newsroom)